• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Siebert Expands Access to Tokenized Securities Through New Collaboration with tZERO and Streamex

    6/29/26 1:42:00 PM ET
    $SIEB
    $STEX
    Investment Bankers/Brokers/Service
    Finance
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SIEB alert in real time by email

    MIAMI and NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) -- Siebert Financial Corp. (NASDAQ:SIEB) ("Siebert"), a diversified financial services company, through its wholly owned subsidiary Muriel Siebert & Co. LLC, today announced a new collaboration with tZERO Group, Inc. ("tZERO") and Streamex Corp. (NASDAQ:STEX) ("Streamex") to expand access to tokenized securities through regulated digital markets infrastructure.

    Through the collaboration, Muriel Siebert & Co. will make Streamex’s GLDY, a gold-backed, yield-bearing tokenized security, available to eligible accredited and institutional investors through Siebert’s wealth management and institutional distribution channels through a private placement conducted under Reg. D Rule 506 (c). GLDY will be supported by tZERO’s regulated digital securities infrastructure, including onboarding, custody, secondary market infrastructure, compliance, and lifecycle services.

    The collaboration represents a practical step in bringing blockchain-enabled financial products into the traditional brokerage experience. Eligible investors can work with a Siebert broker to evaluate GLDY without needing direct blockchain knowledge or separate crypto onboarding.

    "At Siebert, our role is to help investors access what’s next in the markets through a trusted brokerage relationship," said John J. Gebbia, Chief Executive Officer of Siebert. "GLDY is an example of how traditional finance and blockchain-enabled infrastructure can work together without adding complexity for the investor. Clients can speak with their Siebert broker, evaluate whether GLDY fits their goals and risk profile, and, where appropriate, purchase it through a brokerage account."

    For Siebert, the collaboration also supports the continued growth of its investment banking and capital markets platform, with a focus on financial services, FinTech, blockchain, digital assets, and other sectors where traditional market infrastructure is evolving.

    "Tokenized securities are moving from concept to execution," said Ajay Asija, Co-Head of Investment Banking at Siebert. "For issuers, this creates new ways to think about distribution, investor access, and market structure. For investors, it brings emerging asset classes into a more familiar, regulated framework. That is where Siebert can play a meaningful role."

    tZERO will provide the full technology and regulated infrastructure stack supporting Siebert’s digital securities initiative, including investor onboarding, custody, trading infrastructure, and compliance services.

    "Traditional financial institutions increasingly recognize that tokenized securities require more than blockchain technology. They require regulated market infrastructure," said Alan Konevsky, Chairman and Chief Executive Officer of tZERO. "We built tZERO to provide that foundation, giving firms like Siebert a single integrated platform for digital markets."

    Streamex developed GLDY as a tokenized security designed to bring gold-backed exposure and yield-bearing features into a regulated investment structure. Through the collaboration, GLDY can now reach investors through established brokerage and institutional channels.

    "By partnering with Siebert and tZERO, GLDY can reach investors through channels they already know and trust," said Henry McPhie, Co-Founder and Chief Executive Officer of Streamex. "That kind of access is what helps tokenized securities move into the mainstream."



    Notice to Investors

    This communication is provided for informational purposes only and is neither an offer to sell nor a solicitation of an offer to buy any securities in the United States or elsewhere.

    About Siebert Financial Corp.

    Siebert is a diversified financial services company and has been a member of the NYSE since 1967, when Muriel Siebert became the first woman to own a seat on the NYSE and the first to head one of its member firms.

    Siebert operates through its subsidiaries Muriel Siebert & Co., LLC, Siebert AdvisorNXT, LLC, Park Wilshire Companies, Inc., RISE Financial Services, LLC, Siebert Technologies, LLC, StockCross Digital Solutions, Ltd, and Gebbia Media LLC. Through these entities, Siebert provides a full range of brokerage and financial advisory services, including securities brokerage, investment advisory and insurance offerings, securities lending, and corporate stock plan administration solutions. For over 55 years, Siebert has valued its clients, shareholders, and employees. More information is available at www.siebert.com.

    Cautionary Note Regarding Forward-Looking Statements

    The statements contained in this press release that are not historical facts, including statements about our beliefs and expectations, are "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements preceded by, followed by or that include the words "may," "could," "would," "should," "believe," "expect," "anticipate," "plan," "estimate," "target," "project," "intend" and similar words or expressions. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements.

    These forward-looking statements, which reflect beliefs, objectives, and expectations as of the date hereof, are based on the best judgment of management of Siebert. All forward-looking statements speak only as of the date on which they are made. Such forward-looking statements are subject to certain risks, uncertainties and assumptions relating to factors that could cause actual results to differ materially from those anticipated in such statements, including, without limitation, the following: economic, social and political conditions, global economic downturns, including those resulting from extraordinary events; changes and volatility in tariffs and trade policies; securities industry risks; interest rate risks; liquidity risks; credit risk with clients and counterparties; risk of liability for errors in clearing functions; systemic risk; systems failures, delays and capacity constraints; network security risks; competition; reliance on external service providers; new laws and regulations affecting Siebert’s business; net capital requirements; extensive regulation, regulatory uncertainties and legal matters; failure to maintain relationships with employees, customers, business partners or governmental entities; the inability to achieve synergies or to implement integration plans; and other consequences associated with risks and uncertainties detailed in Part I, Item 1A - Risk Factors of Siebert’s Annual Report on Form 10-K for the year ended December 31, 2025, and Siebert’s filings with the SEC.

    Siebert cautions that the foregoing list of factors is not exclusive, and new factors may emerge, or changes to the foregoing factors may occur, that could impact its business. Siebert undertakes no obligation to publicly update or revise these statements, whether because of new information, future events or otherwise, except to the extent required by the federal securities laws.

    For inquiries, please contact:

    Deborah Kostroun

    dkostroun@zitopartners.com

    +1-201-403-8185



    Primary Logo

    Get the next $SIEB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SIEB
    $STEX

    CompanyDatePrice TargetRatingAnalyst
    Streamex Corp.
    $STEX
    11/25/2025$12.00Buy
    Needham
    More analyst ratings

    $SIEB
    $STEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matthews Shawn was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    7/10/26 5:00:04 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Gopaul Kevin Roy was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    7/10/26 5:00:03 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SIEB
    $STEX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/28/26 2:33:28 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SIEB
    $STEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SIEB
    $STEX
    SEC Filings

    View All

    Streamex Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    7/13/26 5:19:19 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/28/26 4:05:31 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/27/26 6:05:10 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SIEB
    $STEX
    Financials

    Live finance-specific insights

    View All

    Streamex Corp. Announces June 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the fourth yield payment for GLDY, its yield-bearing gold asset, occurred on July 17th, 2026. The distribution covers the period from June 1st through June 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is currently earning an ann

    7/17/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the third yield payment for GLDY, its gold-backed, yield-bearing tokenized security, occurred on June 18th, 2026. The distribution covers the period from May 1st through May 31st, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is curren

    6/22/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SIEB
    $STEX
    Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer

    WINTER PARK, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the appointment of Christine Plummer, former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer of Streamex. In this role, Ms. Plummer is expected to oversee the Company's global finance organization, including financial reporting, regulatory compliance, and financial operations as Streamex continues expanding its institutional platform and launching tokenized commodity products. Henry McPhie, Co-Founder & CEO of Str

    3/16/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

    WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex's strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex sa

    3/3/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SIEB
    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors

    Highlights GLDY Class B shares are now available for custody by Inspira Financial, a qualified custodian under the SEC's Custody Rule. Institutional investors, RIA’s, wealth managers, and advisors who hold client assets within Inspira can now access GLDY through infrastructure they already use.Inspira Financial holds over $63 billion in assets across more than 8 million accounts and has serviced over 1,500 funds. As one of the largest directed custodians in the country, Inspira gives GLDY access to an established institutional custody network with deep reach into the traditional finance capital market, representing a significant step-change in GLDY's addressable distribution.Inspira is the

    7/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces June 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the fourth yield payment for GLDY, its yield-bearing gold asset, occurred on July 17th, 2026. The distribution covers the period from June 1st through June 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is currently earning an ann

    7/17/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces 10,000,000 Share Repurchase Program

    WINTER PARK, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced that its board of directors has authorized a new share repurchase program, under which the Company may repurchase, from time to time, up to an aggregate of 10,000,000 shares of the Company’s common stock, par value $0.001 per share, at a price per share up to $2.00, over the next 12 months. Morgan Lekstrom, Executive Chairman of Streamex, said:"The board’s authorization of this repurchase program is a direct expression of our confidence in Streamex’s value and our

    7/7/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SIEB
    $STEX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Siebert Financial Corp. (Amendment)

    SC 13D/A - SIEBERT FINANCIAL CORP (0000065596) (Subject)

    1/23/24 3:54:51 PM ET
    $SIEB
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13D/A filed by Siebert Financial Corp. (Amendment)

    SC 13D/A - SIEBERT FINANCIAL CORP (0000065596) (Subject)

    12/18/23 3:01:27 PM ET
    $SIEB
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13D/A filed by Siebert Financial Corp. (Amendment)

    SC 13D/A - SIEBERT FINANCIAL CORP (0000065596) (Subject)

    6/28/23 7:13:38 PM ET
    $SIEB
    Investment Bankers/Brokers/Service
    Finance